Zdrowie i gospodarka · 26/04/2013

FDA Releases Guidance on Classification of Pharmaceutical Co-Crystals

The Food and Drug Administration (FDA) has made available a guidance document outlining its thinking on the regulatory classification of pharmaceutical co-crystal solid-state forms, which applies to new drug applications and abbreviated new drug applications submitted to the Center for Drug Evaluation and Research (CDER)